1.2000
+0.0250
+(2.13%)
At close: January 17 at 3:39:55 PM GMT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | 0 | 0 | -0.01 | -0.01 |
| Low Estimate | 0 | 0 | -0.01 | -0.01 |
| High Estimate | 0 | 0 | -0.01 | -0.01 |
| Year Ago EPS | -- | -- | -- | -0.01 |
Revenue Estimate
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 2 | 2 |
| Avg. Estimate | -- | -- | 2.66M | 5.48M |
| Low Estimate | -- | -- | 2.5M | 5.4M |
| High Estimate | -- | -- | 2.82M | 5.56M |
| Year Ago Sales | -- | -- | -- | 2.66M |
| Sales Growth (year/est) | -- | -- | -- | 105.82% |
EPS Trend
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -0.01 | -0.01 |
| 7 Days Ago | 0 | 0 | -0.01 | -0.01 |
| 30 Days Ago | 0 | 0 | -0.01 | -0.01 |
| 60 Days Ago | 0 | 0 | -0.01 | -0.01 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| POLX.L | -- | -- | -- | 0.00% |
| S&P 500 | 9.47% | 11.36% | 13.97% | 13.61% |
Related Tickers
NCYT.L Novacyt S.A.
56.70
-3.90%
IOB.DU Ion Beam Applications SA
12.98
-2.41%
2SE.F Sequana Medical NV
2.5400
-1.17%
NEOLA.ST Neola Medical AB (publ)
2.5400
-0.78%
8C4.F CYBERDYNE Inc.
1.0440
-0.19%
CYBQF CYBERDYNE Inc.
1.0350
0.00%
ABT.VI Abbott Laboratories
110.40
+0.84%
2SE.SG Sequana Medical NV
2.5400
-2.68%
EPIS-B.ST Episurf Medical AB (publ)
0.1318
-2.23%
ABL.SG Abbott Laboratories
110.38
+0.44%